Examination of LURAP1L-AS1 in a second breast cancer dataset confirmed elevated LURAP1L-AS1 expression in TNBC (n = 42) compared to normal breast tissue (n = 56), thus suggesting therapeutic window (Fig. 1E). Here, LURAP1L is linked to breast cancer.